As ECM product lines based on human acellular dermal matrix (hADM) continue to emerge, the related market is showing clear signs of expansion. Industry observers note that the market is diversifying beyond conventional ingredient-focused products toward solutions that directly utilize the ECM structure derived from human tissue. Against this evolving medical paradigm, TISSIVO, an acellular allogeneic dermis ECM platform based on human-derived allogeneic dermis (hADM), has been officially launched.

On April 12, at the Korean Society for Aesthetic Plastic Surgery and Laser Medicine (Daemire) held at COEX Magok, Seoul, GENIAN presented clinical case studies and the scientific mechanism of action of MiraColl, an atelocollagen-based product, for the under-eye area. Through a specialist-led lecture, the presentation provided an in-depth review of the product’s biocompatibility and tissue-repairing benefits, drawing strong interest from attending medical professionals.

GENIAN Co., Ltd. officially launched the EXANEL brand and signed a Memorandum of Understanding (MOU) with THUẦN HOA Group, establishing a strategic foundation for global collaboration.